Back
  • Share

Accelerating health sector decarbonisation through medicines carbon footprinting

Pollution, environmental and human health

Yewmaker
Yewmaker

A new report from Public Policy Projects (PPP) highlights the critical role of medicines in delivering the NHS’ net zero commitments, and sets out practical steps to accelerate progress without compromising patient care or the resilience of the medicines supply chain.

  • Date (DD-MM-YYYY)

    15-03-2026 to 15-09-2026

    Available on-demand until 15th September 2026

  • Cost

    Free

  • Education type

    Publication

  • CPD subtype

    On-demand

Description

Medicines are a major contributor to the NHS’ carbon footprint, requiring targeted, data-driven action to meet legislated net zero commitments

Independent, standardised medicines carbon footprint data can support decarbonisation efforts, but clear governance is required to ensure data are used appropriately and to avoid unintended consequences

Embedding carbon considerations into product development and health technology assessment can unlock sustainability by design, aligning improved health outcomes with sustainability and economic growth

Timely action offers an opportunity for the UK to consolidate its leadership in healthcare decarbonisation and shape global standards for sustainable medicines

Contact details